-
Regulatory recap: FDA approvals in urology from the first half of 2025
04 Jul 2025 15:41 GMT
… gozetotide injection, Telix Pharmaceuticals announced. The PET … 25, 2025
Indication: Treatment of uncomplicated urinary … Indication: Patients with benign prostatic hyperplasia (BPH) with prostate volumes … marks the first FDA-approved medication in this …
-
FDA news recap in urology for Q2 2025
03 Jul 2025 20:16 GMT
… FDA approvals (and 1 notable non-approval) ranging from benign prostatic hyperplasia (BPH … marks the first FDA-approved medication in this disease … ) system for the treatment of patients with urinary … ;/www.fda.gov/drugs/drug-approvals-and-databases …
-
ASX June Health Winners: Sector falls 1.05pc but Amplia up 300pc after positive trial news
03 Jul 2025 20:08 GMT
… levels paid in other developed nations.
While the … -stage radiopharmaceutical company Clarity Pharmaceuticals (ASX:CU6) rose … including positive trial results for its lead drug candidate NUZ … a major barrier in treatment of neurodegenerative diseases such …
-
Unhealthy Lifestyle, Chronic Illnesses, and Mental Health Issues Linked to Greater BPH Severity in Elderly Chinese Men: Study
03 Jul 2025 19:06 GMT
… tract symptoms/benign prostatic hyperplasia (LUTS/BPH) and lifestyle choices, … avoid confounding effects from medications like antidepressants, which can … coexisting chronic conditions, and develop personalized treatment strategies. Additionally, they …
-
Analysis of Acupoint Selection and Combinations in Acupuncture Treatment of Trigeminal Neuralgia: A Protocol for Data Mining
03 Jul 2025 06:40 GMT
… 1 Currently, treatments for trigeminal neuralgia include pharmacotherapy, surgery, … Each group or trial must involve more … well-served by medications, many sufferers still … treating benign prostatic hyperplasia based on data mining. Chin J Inform Trad Chin Med …
-
Ternary Solid Dispersions as an Alternative Approach to Enhance Pharmacological Activity
02 Jul 2025 23:21 GMT
… pharmaceutical development.30,31 Disease treatment widely uses various pharmacologically … influence drug activity, with weakly acidic drugs showing … them crucial for treating neurological disorders such as … kinase inhibitors. Cancer Treat Rev. 2015;41( …
-
Genitourinary Drugs Market 2025–2034: In-Depth Forecast on Size, Growth Drivers, Trends & Competitive Outlook
02 Jul 2025 13:22 GMT
… US Food and Drug Administration FDA for Blujepa gepotidacin for treating uncomplicated urinary … Pharmacies, Online Pharmacies
Where additions to segments are included:
1 By Urologicals: Benign Prostatic Hyperplasia BPH Drugs …
-
FDA updates in urology: June 2025
01 Jul 2025 15:35 GMT
… benign prostatic hyperplasia (BPH), and incontinence. Additionally, notable advancements were made in the development … ) for the treatment of adult patients … the first FDA-approved medication in this … Telix Pharmaceuticals announced that the FDA approved …
-
Temporal Relationship Between Treatment Burden and Self-Care and Its Impact on Systolic Blood Pressure and Hypertension Control
01 Jul 2025 12:02 GMT
… treatment burdens often correlate with poorer compliance across pharmacological … Treatment Burden Questionnaire (TBQ), an instrument originally developed … =healthy diet). Medication adherence evaluation incorporated … effectiveness trial. J Gen Intern Med. 2020 …
-
Pomegranate Juice and Prostate Function: A Review
04 Jul 2025 07:44 GMT
… : Prostate diseases, including benign prostatic hyperplasia (BPH) and prostate cancer, … it may interact with medications like statins and warfarin … for prevention and treatment of inflammation and … active compounds. Biomed Pharmacother. 2021;142:111979. …